91Ë¿¹ÏÊÓÆµ

Event

Towards inclusive clinical trials: Insights from the MiNav randomized controlled trial and national research networks

Monday, January 5, 2026 15:30to16:30

Patricia Li, MD, MSc, FRCPC

General Paediatrician | Montreal Children’s Hospital
Associate Professor in Pediatrics | 91Ë¿¹ÏÊÓÆµ

Ananya Tina Banerjee, PhD

Assistant Professor
Equity, Diversity, Inclusion and Anti-Racism (EDIAR) Lead
ÌýSchool of Population and Global Health | 91Ë¿¹ÏÊÓÆµ

The Seminars in Epidemiology organized by the Department of Epidemiology, Biostatistics and Occupational Health at the 91Ë¿¹ÏÊÓÆµ School of Population and Global Health is a self-approved Group Learning Activity (Section 1) as defined by the maintenance of certification program of the Royal College of Physicians and Surgeons of Canada. Physicians requiring accreditation, please complete the Evaluation Form and send to admincoord.eboh [at] mcgill.caÌý

WHEN: Monday, January 5, 2026, from 3:30-4:30 p.m.
WHERE: Hybrid | 2001 91Ë¿¹ÏÊÓÆµ College, Rm 1140 |
NOTE: Patricia Li & Ananya Banerjee will present in-person

Abstract

There is growing recognition that clinical research must reflect the diversity of the populations it aims to serve. Historically, marginalized communities have been underrepresented in trials, which often limits the applicability of evidence. This seminar will highlight a randomized controlled trial co-designed with migrant families and share practical strategies and resources to ensure clinical trials partner with and recruit participants who truly represent the population and condition of interest. We will share our experiences co-leading the MiNav study, a RCT with an embedded qualitative component that was co-designed with migrant parents of children and youth with special healthcare needs to evaluate the effectiveness of a patient navigator intervention in Canada. We will also discuss our work as Equity, Diversity, and Inclusion (EDI) co-leads and members of CIHR-funded research networks such as POPCORN (Pediatric Outcome imProvement through COordination of Research Networks) and ACT (Accelerating Clinical Trials), where we have worked and advocated to embed EDI and anti-discriminatory principles into research design, conduct, and teams.

Learning Objectives

At the end of this talk, attendees will be able to:

  • Explain the historical lack of inclusivity in clinical trials, the current landscape, and why inclusivity is critical;
  • Describe how an RCT can incorporate co-design in partnership with migrant parents;
  • Identify strategies to design and implement inclusive trials and more broadly in research.

Speakers' Bios

Patricia Li is a general paediatrician at the Montreal Children’s Hospital, Associate Professor in Pediatrics at 91Ë¿¹ÏÊÓÆµ, and a FRQS senior clinician-scientist at the CORE of the RI-MUHC. She works as a hospitalist on the inpatient unit and as a consultant in the Multicultural Clinic at the Montreal Children’s Hospital and the CLSC Parc-Extension. She is part of the Northern and Indigenous Child Health Program where she serves Inuit children and families in the community of Ivujivik. Her research includes CIHR-funded research projects across a variety of topics including primary care, hospital care, migrant and Indigenous children, and child health equity.

Ananya Tina Banerjee is an Assistant Professor and the Equity, Diversity, Inclusion, and Anti-Racism lead at the School of Population & Global Health, 91Ë¿¹ÏÊÓÆµ. Her interdisciplinary epidemiologic and qualitative research uses community-based participatory approaches to address health inequities using a structural and intersectional lens. This work is grounded in collaboration with racialized communities and funded by the Tri-Council Agencies, the Lancet Commission, and the Public Health Agency of Canada. She also serves on The Lancet’s International Advisory Board for Racial Inequalities.

Ìý

Ìý

Ìý

Ìý

Ìý

Back to top